vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and COLONY BANKCORP INC (CBAN). Click either name above to swap in a different company.

COLONY BANKCORP INC is the larger business by last-quarter revenue ($39.9M vs $23.1M, roughly 1.7× ADC Therapeutics SA). Over the past eight quarters, COLONY BANKCORP INC's revenue compounded faster (19.6% CAGR vs 13.7%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

Colony Bankcorp Inc is a US-based bank holding company that operates Colony Bank. It provides a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving retail customers and small-to-medium enterprises across the state of Georgia.

ADCT vs CBAN — Head-to-Head

Bigger by revenue
CBAN
CBAN
1.7× larger
CBAN
$39.9M
$23.1M
ADCT
Faster 2-yr revenue CAGR
CBAN
CBAN
Annualised
CBAN
19.6%
13.7%
ADCT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ADCT
ADCT
CBAN
CBAN
Revenue
$23.1M
$39.9M
Net Profit
$8.2M
Gross Margin
Operating Margin
-77.7%
Net Margin
20.6%
Revenue YoY
36.4%
Net Profit YoY
24.1%
EPS (diluted)
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
CBAN
CBAN
Q1 26
$39.9M
Q4 25
$23.1M
$36.9M
Q3 25
$15.8M
$32.8M
Q2 25
$18.1M
$32.5M
Q1 25
$17.4M
$30.0M
Q4 24
$16.9M
$30.8M
Q3 24
$18.0M
$28.6M
Q2 24
$17.0M
$27.9M
Net Profit
ADCT
ADCT
CBAN
CBAN
Q1 26
$8.2M
Q4 25
Q3 25
$-41.0M
$5.8M
Q2 25
$-56.6M
$8.0M
Q1 25
$-38.6M
$6.6M
Q4 24
Q3 24
$-44.0M
$5.6M
Q2 24
$-36.5M
$5.5M
Operating Margin
ADCT
ADCT
CBAN
CBAN
Q1 26
Q4 25
-77.7%
25.9%
Q3 25
-196.6%
22.2%
Q2 25
-244.1%
30.9%
Q1 25
-163.5%
27.6%
Q4 24
-191.8%
28.8%
Q3 24
-197.4%
24.6%
Q2 24
-170.5%
24.8%
Net Margin
ADCT
ADCT
CBAN
CBAN
Q1 26
20.6%
Q4 25
Q3 25
-260.1%
17.7%
Q2 25
-313.2%
24.6%
Q1 25
-221.8%
22.0%
Q4 24
Q3 24
-244.1%
19.7%
Q2 24
-214.6%
19.6%
EPS (diluted)
ADCT
ADCT
CBAN
CBAN
Q1 26
Q4 25
$0.04
$0.42
Q3 25
$-0.30
$0.33
Q2 25
$-0.50
$0.46
Q1 25
$-0.36
$0.38
Q4 24
$-0.26
$0.43
Q3 24
$-0.42
$0.32
Q2 24
$-0.38
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
CBAN
CBAN
Cash + ST InvestmentsLiquidity on hand
$261.3M
$295.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$380.4M
Total Assets
$323.1M
$3.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
CBAN
CBAN
Q1 26
$295.8M
Q4 25
$261.3M
Q3 25
$234.7M
Q2 25
$264.6M
Q1 25
$194.7M
Q4 24
$250.9M
Q3 24
$274.3M
Q2 24
$300.1M
Total Debt
ADCT
ADCT
CBAN
CBAN
Q1 26
Q4 25
$258.1M
Q3 25
Q2 25
Q1 25
Q4 24
$248.0M
Q3 24
Q2 24
Stockholders' Equity
ADCT
ADCT
CBAN
CBAN
Q1 26
$380.4M
Q4 25
$-185.8M
$375.9M
Q3 25
$-238.2M
$302.3M
Q2 25
$-199.2M
$293.9M
Q1 25
$-238.2M
$286.9M
Q4 24
$-202.6M
$278.7M
Q3 24
$-171.9M
$276.1M
Q2 24
$-131.7M
$264.7M
Total Assets
ADCT
ADCT
CBAN
CBAN
Q1 26
$3.7B
Q4 25
$323.1M
$3.7B
Q3 25
$289.8M
$3.2B
Q2 25
$321.6M
$3.1B
Q1 25
$272.5M
$3.2B
Q4 24
$322.0M
$3.1B
Q3 24
$349.1M
$3.1B
Q2 24
$371.8M
$3.0B
Debt / Equity
ADCT
ADCT
CBAN
CBAN
Q1 26
Q4 25
0.69×
Q3 25
Q2 25
Q1 25
Q4 24
0.89×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
CBAN
CBAN
Operating Cash FlowLast quarter
$-31.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
CBAN
CBAN
Q1 26
Q4 25
$-31.1M
$-5.5M
Q3 25
$-29.6M
$14.4M
Q2 25
$-24.1M
$15.8M
Q1 25
$-56.3M
$17.9M
Q4 24
$-21.9M
$23.4M
Q3 24
$-25.0M
$20.5M
Q2 24
$-32.8M
$1.1M
Free Cash Flow
ADCT
ADCT
CBAN
CBAN
Q1 26
Q4 25
$-6.9M
Q3 25
$14.1M
Q2 25
$15.8M
Q1 25
$-56.6M
$17.6M
Q4 24
$-21.9M
$22.3M
Q3 24
$-25.3M
$20.2M
Q2 24
$-32.9M
$990.0K
FCF Margin
ADCT
ADCT
CBAN
CBAN
Q1 26
Q4 25
-18.7%
Q3 25
42.9%
Q2 25
48.5%
Q1 25
-325.2%
58.7%
Q4 24
-129.8%
72.5%
Q3 24
-140.2%
70.6%
Q2 24
-193.0%
3.5%
Capex Intensity
ADCT
ADCT
CBAN
CBAN
Q1 26
Q4 25
0.0%
3.7%
Q3 25
0.0%
1.1%
Q2 25
0.0%
0.3%
Q1 25
1.5%
1.2%
Q4 24
0.5%
3.5%
Q3 24
1.2%
1.0%
Q2 24
0.2%
0.5%
Cash Conversion
ADCT
ADCT
CBAN
CBAN
Q1 26
Q4 25
Q3 25
2.48×
Q2 25
1.99×
Q1 25
2.71×
Q4 24
Q3 24
3.64×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADCT
ADCT

Segment breakdown not available.

CBAN
CBAN

Net Interest Income$29.2M73%
Noninterest Income$10.7M27%

Related Comparisons